NL-OMON34173已完成不适用
Efficacy of a proprietary compound B in a humanized mouse model of psoriasis - Pre-clinical efficacy of compound B in psoriasis
TNO0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Psoriasis patients: Adults (m/f) with a mild form of psoriasis vulgaris (PASI score of maximal 6). Patients are allowed to use localcorticosteriods or ointments to prevent dry skin (see appendix 2).
排除标准
- •Psoriasis patients: These patients have not received light therapy or another form of systemic treatment (methotrexaat, cyclosporin A,anti-TNF treatments). Gender or age of the adults are not a exclusion criteria.(see appendix 2)
研究者
相似试验
已完成
不适用
Efficacy analysis of a novel compound in a humanized mouse model of psoriasisflaking diseasePsoriasis1000381610014982NL-OMON37226TNO16
已完成
不适用
Efficacy analysis of a novel compound in a humanized mouse model for psoriasis and development of the humanized mouse modelflaking diseasePsoriasis1000381610014982NL-OMON38904TNO33
已完成
不适用
Efficacy of two novel compounds in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON35972TNO29
尚未招募
2 期
Add On Effect Of Basti In Non-Alcoholic Fatty Liver Disease.CTRI/2024/03/064543All India Institute Of Ayurveda
招募中
不适用
Efficacy of a three novel compounds in a humanized mouse model of psoriasisflaking diseasepsoriasis1000381610014982NL-OMON35935Pfizer24